DRUG THERAPIES

Treatment Options

Ascend Infusion provides intravenous (IV) drug therapies primarily targeting autoimmune diseases, chronic inflammatory conditions, and certain cancers. It focuses on conditions such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and psoriasis.

Below is a list of drug therapies currently offered. If your prescribed treatment isn’t listed below, Ascend Infusion will work with the drug manufacturer to gain the necessary educational materials and in-service training to deliver it safely to your patients.

shutterstock-1465423343

Drug Therapies

Actemra (Tocilizumab)
  • Rheumatoid Arthritis (RA)
  • Giant Cell Arteritis (GCA)
Benlysta (Belimumab)
Briumvi (Ublituximab)
Cimzia (Certolizumab Pegol)
Cosentyx (Secukinumab)
Entyvio (Vedolizumab)
Ilumya (Tildrakizumab)
Infliximab (Remicade, Renflexis, Unbranded Infliximab)
Krystexxa (Pegloticase)
nurse-holding-dextros

Nucala (Mepolizumab)
  • Eosinophilic Asthma
  • Eosinophilic Granulomatosis with Polyangiitis (EGPA)
  • Chronic Rhinosinusitis with Nasal Polyps (CRSwNP
Ocrevus (Ocrelizumab)
Omvoh (Mirikizumab)
Orencia (Abatacept)
Reclast (Zoledronic Acid)
Rituximab
Saphnelo (Anifrolumab)
Simponi Aria (Golimumab)
Skyrizi (Risankizumab)
Tysabri (Natalizumab)
Stelara
Tepezza
Tremfya

Accepted Insurance

Ascend Infusion works with all major health insurance companies to maximize benefits and decrease out-of-pocket expenses for infusion therapy. We are also in-network with all major health insurance companies and accept commercial insurance, Medicare, Medicare Advantage, and Medicaid to expand access to care.
Ascend Infusion is growing, adding locations, and expanding our in-network healthcare plans. Please contact us with any questions.

START A REFERRAL